chrisvoncsefalvay/vaers-outcomes huggingface dataset:
i had a tear in my retina; i started seeing floaters in my right eye about 4 days after my first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 12:00 (Lot number: EN6204) at the age of 56 years as dose 1, single for covid-19 immunisation. The Relevant medical history included: "lupus" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient did not take any other vaccine in four weeks. The following information was reported: RETINAL TEAR (medically significant), outcome "recovering", described as "I had a tear in my retina"; VITREOUS FLOATERS (non-serious) with onset Mar2021, outcome "recovering", described as "I started seeing floaters in my right eye about 4 days after my first vaccine". She started seeing floaters in her right eye about 4 days after her first vaccine, dark black then the next day turned into a black line. She went to the ophthalmologist right away. She had a tear in her retina, had to get emergency surgery (emergency laser eye surgery) the next day, then was still seeing 5 to 7 tiny floaters grey. She saw eye surgeon again he said it was healing but could not promise all floaters would go away. The events "i had a tear in my retina" and "i started seeing floaters in my right eye about 4 days after my first vaccine" were evaluated at the physician office visit. The patient later received second dose of bnt162b2 (BNT162B2), lot number: ER8737, on 19Apr2021 at 12:00, in left arm as dose 2, single for Covid-19 immunization, by that afternoon dark black larger floater returned, her retina could get detached now she was worried as she had another tear.  No follow-up attempts are possible. No further information is expected.
I had a sinus infection that I went to an infectious disease doctor about and he discovered it and he then sent me to an ENT Doctor for further treatment. The treatment was a nasal surgery to the right side of my face due to occlusion, a successful surgery was performed and a CT Scan ordered every six months.
This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 74-year-old female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On 8th April 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and not applicable after receiving SHINGRIX, the patient experienced feeling unwell, pain and product supply issue. On an unknown date, the outcome of the feeling unwell and pain were recovered/resolved and the outcome of the product supply issue was unknown. It was unknown if the reporter considered the feeling unwell and pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. After receiving 1st dose, the patient did not feel well. She also experienced aches around her middle on one side. It extended from her front around to her back, but only on one side. The aches went away after a couple days. Due to the backorder of vaccine, it was expected that the patients would be late for 2nd dose. Consent to follow up was given.
First dose of vaccine received on 12/18/20: no adverse reaction, felt great Second dose of vaccine received Thursday night, 1/7/21: no adverse reaction that night but woke up with sore L arm in the morning. So, no unusual side effect for 24h, then experienced on Friday night: headaches, chills, body ache, fatigue. Took 650 mg of acetaminophen. Same symptoms on Saturday with increase in intensity, plus mild fever in the evening at 99.6 F (instead of 97.4 F which is "my normal"), nausea, painful eye balls, sensitivity to light and noise, loss of appetite. Took 650 mg tabs of  acetaminophen throughout the day per bottle instruction.  Extreme fatigue Saturday night and severe headaches, fever at 100.2 F that night, treated with acetaminophen. By Sunday night temperature was 100.9 F, extreme fatigue and severe headaches and painful eye balls, heart rate racing up to 120 BPM when moving from bathroom to living room. Went back down to 65 BPM after about 1min at rest. Tried massages of upper body to loosen muscle, seemed to help with bodyache. Spent Saturday through Tuesday at home. Rapid covid 19 test negative. Back to work on Wednesday.
Within 10 minutes of receiving the vaccine, developed "blackening" vision and then lost consciousness. Uncertain about time of loss of consciousness. Other symptoms included pallor, fast heart rate, sweating, nausea and loss of bladder function. No treatment required, seen in the ED and recovered without treatment.   Because she was driving a car at the time, she rear-ended the car in front of her and the airbags deployed. Underwent evaluation for motor vehicle accident as well in the ED with no injuries noted.
I had my vaccination on 06/22/2022. On 10/12/2022 I had COVID-19 symptoms to include scratchy throat and fever. I went to urgent care and tested COVID-19 Positive on 10/13/2022. I am on Eloquence so they didn't prescribe any other medication. I currently feel fine on 12/27/2022.
Information has been received from a registered pharmacist reporting on herself, who on an unknown date was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number not reported, Route not provided). It was reported that one day after vaccination, she developed a "huge, swollen and red bump" at injection site which resolved after several days without requiring medical intervention. Additional information has been requested.
OBSTRUCTIVE SLEEP APNEA HYPOXIA 1/31/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient was supposed to received pediatric dose of Pfizer COVID-19 vaccine, but instead, received the adult dose. This occurred in the afternoon, around 3 PM of 11/8/21. Spoke to patient's mom around 5PM of 11/8/21, and she stated that patient was in a good mood, no symptoms as of yet. Informed mom to look out for any serious adverse events (chest pain, heart palpitations). Spoke to mom again on 11/9/21 at 12PM, and she stated that patient had developed a sore/tender arm, but no other symptoms as of yet.
Patient passed out immediately after receiving vaccine. Pale, diaphoretic, and hypotensive (80 systolic). Patient sent to the ED.
CHILLS AND SHAKING THE WHOLE FIRST DAY AND EVENING; WEAKNESS AND OVERALL LETHARGY; VERY SENSITIVE AND PAINFUL SKIN SURFACES--ALL OVER BODY, EVEN SKIN ON SCALP.  ALMOST NO PAIN AT INJECTION SITE. FIRST SHINGRIX SHOT IN OCTOBER GAVE ME ALL OF THE ABOVE, PLUS A RASH/ITCHING ON THE TRUNK OF MY BODY.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (slightly sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 vaccination. No medical history reported. On 04-Feb-2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain in extremity (slightly sore arm). At the time of the report, pain in extremity (slightly sore arm) resolved. mRNA-1273 (Moderna COVID-19 vaccine), unknown dosing remained unchanged. The reporter did not provide any causality assessment, concomitant product use, treatment information or lab details. This case linked to MOD-2021-051409 (patient link).
DEVELOPED S/S OF COVID 18 DAYS AFTER VACCINATION, TESTED ON DAY 19 POST VACCINATION, AND RESULTED POSITIVE ON SARS 2019 n-Cov PCR ON DAY 20 POST VACCINATION. PT DID ALSO HAVE A WORK EXPOSURE ON 1/21/21, AND HUSBAND IS ALSO A POSITIVE CASE. S/S WERE: COUGH, SINUS CONGESTION, LOSS OF TASTE AND SMELL, HEADACHE, AND SNEEZING.
Patient received his second dose of Moderna at 1210, with his dad. He reported he had mild anxiety from past injection but did not passed out.  Patient directed to the waiting area and wait for 15 minutes. While sitting in his chair, patient lost consciousness and fell out of his chair onto his right side and striking the right side if his head.  Emergency Response Team was called. Patient passed out for about 15-20 seconds upon waking, BP was 100/56 HR 44 and alert and oriented x3. After 10 minutes VS was rechecked and it was 130/ 68 HR 76, pain level 7/10. Patient reported no medical history, not taking any medication. EMT arrived, report was given. Patient dad stated that he will drive his son to the Hospital to get check.
On February 15, 2021, had fever and MASSIVE HEADACHE. Got worse each day. Went to ER on 2/19/21, was treated and release.  Found unconscious in home on 2/20/21. Was hospitalized on 2/20/2021.   Was diagnosed with varicella meningitis on 2/22/2021. Hosptalized till 2/25/2021. Still not well
sore in the arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program Support (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "unknown", described as "sore in the arm".  Additional information: Is the reporter a healthcare professional (HCP): UNKNOWN, Occupation/Specialty: Unknown, Is the reporter's contact information available to you or a sub-contracted party: UNKNOWN, Is the reporter the prescribing HCP: UNKNOWN. Verbatim and Event Description: (name) originally called to ask whether the first vaccine dose is exactly the same as the 2nd vaccine dose. (Name) was scheduled to have his 1st vaccine supposedly on 23Mar2021. However, his niece helped him get an earlier schedule which is 02Mar2021, but on the different facility. (Name) had his 1st vaccine last 02Mar2021 and is scheduled to return for the 2nd dose on 23Mar2021. He is now wondering whether the 2nd dose of the vaccine is the same as the vaccine of the other facility where he was originally scheduled to get his first dose. Later in the conversation, he reported that he experienced a sore in the arm within 2 days after his first shot. Medical Information: Were any unaddressed medical questions referred or forwarded to Medical Information: No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
expiratory wheezing and coughs; my spo2 was 92/94; expiratory wheezing and coughs; throat ache; shortness of breath; tachycardia; This is a spontaneous report from a contactable consumer.  A 39 year old female consumer (patient) reported that received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number ew0185), in the right arm on 30May2021 at 12:30 (at the age of 39-years-old) at single dose for COVID-19 immunization. The patient was not pregnant. patient's history included seasonal allergy with rhinorrhea and sneezing. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant drugs included cromolyn sodium nasal spray. The patient reported on 03Jun2021 throat ache started after vaccine, then she woke up midnight with shortness of breath and tachycardia. She had expiratory wheezing and coughs. The next night the same thing happened and this time wheezing was pronounced and her husband could easily hear it. She was not asthmatic. She had to use cromolyn, psedoephedrine, fluticasone to reduce the symptoms. Her SPO2 was 92/94 and her husband 98. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was unknown.
Swelling, itching, redness at site of varicella vaccine adminsitration.
Pt  said two or three days after she received the vaccine she began to itch over her entire body.  She said even her fingertips itch.  She has not developed a rash.  The itch is disseminated over her entire body, not localized to one particular area.  She said she has had body wide itching before but not to this extreme.  She has not taken anything for it.  She denied any other symptoms.  The itch continues unabated.
1st dose of COVID 19 vaccine administered on 7/28/2021 and 2nd dose of COVID 19 was erroneously provided early on 7/30/2021.  reported no signs or symptoms at this time.
sore; tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (sore) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN (sore) and FATIGUE (tired). At the time of the report, PAIN (sore) and FATIGUE (tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
On 8/18/08 client got Dtap and IPV in left arm. Got MMR, varicella and Hep A in right arm. Mother states left arm got red right away.  Redness and swelling increased in 1st 24 hours and covered arm from elbow to shoulder.  Started vomiting that night and cont. for about 24 hours.  Took child to doctor on 8/21/08 for well-check and was told by doctor that she should not get tetanus shot in future.  Child has recovered completely as of 8/21/08.
This spontaneous report as received from a nurse refers to a 15 year old female patient. On 12-JUN-2014, 1 day before her 16th birthday, she was vaccinated with a dose of VAQTA 50/1.0 U/ml (an adult dose was inadvertently administered: 1 ml intramuscularly; lot# and expiration date not provided). No adverse effects were reported. Additional information has been requested.
We were informed the patient passed away 2 days after receiving the vaccine.  We do not have any details about what happened, we were informed by one of his employees.   We have no knowledge that this had anything to do with the vaccination in any way.
I had my vaccination on 09/28/2022. I started to experience fatigue in 12/2022. I fainted out of bed on 03/16/2023 at 3am. My heart rate was 94 and my blood pressure was very low and the next reading was a HR of 90 and blood pressure of106/76. These readings were at rest. On 03/17/2023 my blood pressure was 102/63 heart rate was 95 101/67. The second reading my heart rate was 98 and blood pressure was 106/66. I never had a history of heart problems. My doctor ordered a Holter Monitor to monitor my heart rate in soon but I am waiting for delivery of the device to my location.
I'm still not doing very well; Headaches; I'm having problems with my hearing; This spontaneous case was reported by a consumer and describes the occurrence of HYPOACUSIS (I'm having problems with my hearing), MALAISE (I'm still not doing very well) and HEADACHE (Headaches) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2022, the patient experienced HYPOACUSIS (I'm having problems with my hearing) and HEADACHE (Headaches). On an unknown date, the patient experienced MALAISE (I'm still not doing very well). At the time of the report, HYPOACUSIS (I'm having problems with my hearing), MALAISE (I'm still not doing very well) and HEADACHE (Headaches) had not resolved.            Concomitant medications were not reported. Treatment details were not reported.
He went to the hospital and was told he had a blood clot in his leg; his leg 'blew up and swelled up double the size'; This is a spontaneous report from a non-contactable consumer (patient).   A male patient of an unspecified age received bnt162b2 (COMIRNATY, solution for injection) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received BNT162B2 on an unspecified date as dose 1, single for COVID-19 immunization and experienced leg started to hurt. On an unspecified date, the patient went to the hospital and was told he had a blood clot in his leg and 'blew up and swelled up double the size'. The patient stated that he was being followed by doctor and was given blood thinners. The patient underwent lab tests and procedures which included ultrasound scan: blood clot in his leg (diagnosis via ultrasound) on an unspecified date. The outcome of the events was unknown, events led to a physician office visit and treatment (blood thinners) received.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
"big spot" at the injection site; "itches real bad"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad") in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad"). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE REACTION ("big spot" at the injection site) and VACCINATION SITE PRURITUS ("itches real bad") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment drug: Benadryl No concomitant medications provided. No medical history reported
extreme vertigo/mini stroke/symptoms were very similar to a mini stroke; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (extreme vertigo/mini stroke/symptoms were very similar to a mini stroke) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939909, 011a21a and 036a21a) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included SIMVASTATIN (STATIN [SIMVASTATIN]), MULTIVITAMINS [VITAMINS NOS] and MAGNESIUM for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VERTIGO (extreme vertigo/mini stroke/symptoms were very similar to a mini stroke). At the time of the report, VERTIGO (extreme vertigo/mini stroke/symptoms were very similar to a mini stroke) had resolved.            Patient was never tested positive for COVID-19. Patient did not received other vaccines within 1 month prior to Moderna COVID-19 vaccine. Following vaccination to the 1st booster patient started to experience the next morning extreme vertigo for about 30 minutes. symptoms came and went, were very similar to a mini stroke. Patient to seek medical care, in touch with doctor and follow up in the next week with neurologist, patient could not conclude if it was a mini stroke or a reaction to the shot. Treatment details was not reported by the reporter.
Localized reaction (pain, redness, and swelling at injection site. Swelling and redness measure about 10 cm).
Developed chest tightness and rash to b/l hands, hips and back, urticaria present.
This spontaneous report as received from a nurse refers to a 08-week-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 21-SEP-2017, the patient was vaccinated with improperly stored ROTATEQ (dosing details were not reported) (lot # M042170, expiry date: 22-JUN-2018) orally for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
PCP noted  erythema, warmth, swelling approximately 8 cm in diameter at injection site on 3/31 at 11:00 am in office
Runny nose, cough, hoarseness, tight in chest approx 5:30 pm headache, eyes red & itchy, lip swelling, tingling; and hoarseness and tightness in chest worse. Approx 9:30 pm - called nurse line at 10:00 & told to go to ER or urgent care - 10:15 - went to urgent care. Given epi-pen, steroid injection, albuterol breathing treatment & PATADAY eye drops.
light headed; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (light headed) and HEADACHE (bad headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced DIZZINESS (light headed) and HEADACHE (bad headache). At the time of the report, DIZZINESS (light headed) and HEADACHE (bad headache) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was unknown.  Caller stated got the booster dose from the Moderna vaccine in the morning along with their spouse. Patient had a bad headache in afternoon for a little while and was light headed.  Patient got the first 2 doses of the Moderna vaccine as well.
11/10/2004 Redness, warmth, swelling at injection site (right upper arm); 16.5x17.5cm.
Patient stated she waited the full 20 minutes downstairs without any reactions, however started feeling itchy and swollen shortly after, which prompted her to come up to the caregiver health office.  An RN visually assessed patient and patient was not SOB and able to speak in full sentences. Patient states she felt as if she was "about to have a panic attack" because of a possible reaction. The RN prompted the patient to go down to the ED if she felt she was having a reaction to the covid vaccination.  Patient checked into Medical Center Emergency Department
101.5 fever, nausea,  significant bilateral arm pain. Both deltoid areas severely hot to touch, very swollen to the point of being firm, and very painful to touch.